Skip to main content

UBS Group AG

Position in AMLX — Amylyx Pharmaceuticals, Inc.

CIK 1610520 ZURICH, V8

Position in AMLX

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$4,508,033
-$2,055,307 QoQ
Shares Held
324,319
-40.3% QoQ
Ownership
0.292%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AMLX Over Time

Shares Held

Position Value (USD)

Derivatives in AMLX

reported options exposure · as of Jun 30, 2023
CallValue
$0
CallShares
0
PutValue
$601,803
PutShares
27,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

UBS Group AG holds $1,524,520,292 across 81 Drug Manufacturers - Specialty & Generic names. AMLX ranks #27 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AMLX

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $4,508,033 324,319
2025-12-31 $6,563,340 543,323
2025-09-30 $19,086,759 1,404,471
2025-06-30 $8,033,934 1,253,344
2025-03-31 $4,915,031 1,388,427
2024-12-31 $2,432,520 643,524
2024-09-30 $742,204 229,076
2024-06-30 $57,263 30,139
2024-03-31 $598,026 210,573
2023-12-31 $574,285 39,014
2023-09-30 $84,427 4,611
2023-06-30 $1,597,797 74,075
2023-06-30 $601,803 27,900
2023-03-31 $818,586 27,900
2023-03-31 $1,365,864 46,553
2023-03-31 $1,631,304 55,600
2022-12-31 $1,030,905 27,900
2022-12-31 $128,474 3,477
2022-09-30 $3,659,500 130,000
2022-09-30 $112,234 3,987
2022-06-30 $3,409 177
2022-03-31 $53,417 4,157